NOWADAY INDICACIONS TO SURGERY FOR LUNG TUBERCULEMAS
Abstract
A comparative study of clinical, X-ray and microbiological examination of 153 patients with primary diagnosis of «lung tuberculema» (TL) before and after surgery was performed.
The examination of surgical material included morphological, microbiological and molecular-genetic (PCR in real time) studies. The diagnosis of TL was confirmed in 78.8% of patients, in 61.4% MBT was found (29.4% in sputum), in 57.5% – MDR and XDR was detected. Drug administration more than 8 months in 26 patients with TL led to 12.6 times rising of the expression of the MDR1 gene, which is responsible for the synthesis of the Pgp protein. This indicated the formation of resistance of lung cells to drugs of the 1 st series such as rifampicin, which was initially obtained by 63.4% of patients. Examination of the surgical material ensures verification of the diagnosis, creates conditions for adequate chemotherapy.
About the Authors
M. A. BagirovRussian Federation
L. N. Lepeha
Russian Federation
S. S. Sadovnikova
Russian Federation
N. L. Karpina
Russian Federation
E. V. Krasnikova
Russian Federation
M. V. Erokhina
Russian Federation
References
1. Авербах М.М. Туберкулемы легкого. – М.: Медицина, 1969. – 336 с.
2. Винокуров И.И. Клинико-морфологическое обоснование хирургического лечения туберкулем легких // Пробл. туберкулеза. – 2009. – № 4. – С. 28-30.
3. Диденко Г.В. Результаты хирургического лечения больных туберкулемой легкого // Пробл. туберкулеза. – 2007. – № 11. – С. 26-28.
4. Ерохина М.В., Александрова Е.А., Онищенко Г.Е. Развитие устойчивости к рифампицину в эпителиальных клетках in vitro // Туберкулез и болезни легких. – 2006. – № 8. – С. 58-61.
5. Ерохина М.В., Лепеха Л.Н., Эргешов А.Э. Возможность формирования устойчивости моноцитарных и эпителиальных клеток к рифампицину // Туберкулез и социально значимые заболевания. – 2016. – № 2. – С. 59-65.
6. Жингель И.П. Туберкулема легкого: дисс. … д-ра мед. наук. – М.,1974. – 214 с.
7. Отраслевые и экономические показатели противотуберкулезной работы в 2012–2013 гг. Аналитический обзор основных показателей и статистические материалы / Под ред. С.А. Стерликова – М.: РИО ЦНИИОИЗ, 2014. – 72 с.
8. Туберкулез органов дыхания: руководство для врачей / Под ред А.Г. Хоменко. – 2-е изд. – М.: Медицина, 1988. – 576 с.
9. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins // J. Natl. Cancer Inst. – 2000. – Vol. 92. – N. 16. – P. 1295-1302.
10. Haydel S. Extensively drug-resistant tuberculosis: a sign of the times and an impetus for antimicrobial discovery // Pharmaceuticals (Basel). – 2010. – Vol. 3. – N. 7. – P. 2268-2290.
11. Scheffer G.I., Pijnenborg A.C.L.M., Smit E.F. et al. Multidrug resistance related molecules in human and murine lung // J. Clin. Pathol. – 2002. – Vol. 55. – P. 332-339.
12. Schuetz E.G., Schinkel A.H., Relling M.V., Schuetz J.D. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans // Proc. Natl. Acad. Sci. USA. – 1996. – Vol. 93. – N. 9, – P. 4001-4005.
13. Trussardi-Regnier A., Millot J.M., Gorisse M.C. et al. Detection of drug-resistance genes using single bronchoscopy biopsy specimens // Oncol. Rep. – 2007. – Vol. 18. – Р. 703-708.
14. Trauner A., Borrell S., Reither K. et al. Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy // Drugs. – 2014. – Vol. 74. – P. 1063-1072.
Review
For citations:
Bagirov M.A., Lepeha L.N., Sadovnikova S.S., Karpina N.L., Krasnikova E.V., Erokhina M.V. NOWADAY INDICACIONS TO SURGERY FOR LUNG TUBERCULEMAS. Tuberculosis and socially significant diseases. 2018;(2):43-48. (In Russ.)